ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 97 filers reported holding ALBIREO PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $243,762 | +10.3% | 11,280 | -1.2% | 0.00% | – |
| Q3 2022 | $221,000 | -1.8% | 11,416 | +0.7% | 0.00% | – |
| Q2 2022 | $225,000 | -30.6% | 11,335 | +4.5% | 0.00% | – |
| Q1 2022 | $324,000 | +37.9% | 10,846 | +7.3% | 0.00% | – |
| Q4 2021 | $235,000 | -19.0% | 10,112 | +9.0% | 0.00% | – |
| Q3 2021 | $290,000 | -10.5% | 9,279 | +0.9% | 0.00% | – |
| Q2 2021 | $324,000 | -23.6% | 9,200 | -23.5% | 0.00% | – |
| Q1 2021 | $424,000 | -40.4% | 12,028 | -36.5% | 0.00% | – |
| Q4 2020 | $711,000 | +214.6% | 18,929 | +172.8% | 0.00% | – |
| Q1 2018 | $226,000 | – | 6,939 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 330,407 | $5,409,000 | 2.53% |
| Perceptive Advisors | 1,960,139 | $31,931,000 | 0.83% |
| Birchview Capital, LP | 48,000 | $786,000 | 0.70% |
| Chicago Capital, LLC | 492,878 | $8,068,000 | 0.65% |
| Artal Group S.A. | 588,125 | $9,628,000 | 0.41% |
| PA Capital LLC | 23,198 | $380,000 | 0.34% |
| Eversept Partners, LP | 78,029 | $1,277,335 | 0.32% |
| HEARTLAND ADVISORS INC | 150,000 | $2,456,000 | 0.26% |
| ArrowMark Colorado Holdings LLC | 972,372 | $15,918,000 | 0.21% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 25,268 | $414,000 | 0.14% |